Amylyx Pharmaceuticals, Inc. employees and revenue per employee

AMLX · Biotechnology · $3.35B market cap

Amylyx Pharmaceuticals, Inc. had 123 employees at the end of fiscal Dec 2024, down 68.0% from a year earlier. Revenue for the year was $87.4M, down 77.1% from a year earlier, or $710K per employee. Revenue fell, and headcount fell or held flat with it.

Employees

123

-68.0% YoY

Revenue

$87.4M

-77.1% YoY

Revenue / employee

$710K

Peer median $457K

Rank in industry

42 of 110

Biotechnology

Open roles

49

398 per 1,000 staff

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2022
09231846'22'23'24Revenue 393Staff 47

Hover a year for the numbers.

AMLX employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 2024123$87.4M$710K-68.0%-77.1%
Dec 2023384$381M$992K+46.6%+1612.9%
Dec 2022262$22.2M$85K——

Open roles on its job board: 49 (398 per 1,000 staff, against its latest annual headcount), as of 2026-11-20. Tracked since 2026-10-03. No 90 day change yet.

Employees, last six fiscal years
262'22384'23123'24
Revenue per employee, last six fiscal years
$85K'22$992K'23$710K'24

Amylyx Pharmaceuticals, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
ZVRA
Zevra Therapeutics, Inc.
61$106M$1.75MEfficient growth
ASMB
Assembly Biosciences, Inc.
73$72.3M$990KLeaner
AMLX
Amylyx Pharmaceuticals, Inc.
123$87.4M$710KContracting
FDMT
4D Molecular Therapeutics, Inc.
196$85.2M$435KLeaner
ZYME
Zymeworks Inc.
264$106M$401KLeaner
VRDN
Viridian Therapeutics, Inc.
252$70.8M$281KEfficient growth
NRIX
Nurix Therapeutics, Inc.
317$84.0M$265KEfficient growth
MGTX
MeiraGTx Holdings plc
400$81.4M$203KEfficient growth
CYTK
Cytokinetics, Incorporated
673$88.0M$131KEfficient growth
Every Healthcare company

Questions about Amylyx Pharmaceuticals, Inc.

How many employees does Amylyx Pharmaceuticals, Inc. have?
Amylyx Pharmaceuticals, Inc. reported 123 employees for the fiscal year ending Dec 2024, in the annual report it filed on March 4, 2025. That is down 68.0% from a year earlier.
What is Amylyx Pharmaceuticals, Inc.'s revenue per employee?
Amylyx Pharmaceuticals, Inc. brought in $87.4M of revenue in fiscal Dec 2024, which is $710K per employee. That ranks 42 of 110 companies we track in Biotechnology, where the median is $457K.
Is Amylyx Pharmaceuticals, Inc. hiring?
Amylyx Pharmaceuticals, Inc.'s public job board listed 49 open roles on November 20, 2026, about 398 per 1,000 staff.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare AMLX with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Amylyx Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed March 4, 2025. This is data, not a recommendation to buy or sell AMLX.